- $485.75m
- $508.98m
- $185.36m
- 92
- 58
- 86
- 93
Annual cashflow statement for biote, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 21.3 | 29.2 | 32.6 | 1.32 | -2.81 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.837 | 1.71 | 1.16 | 23.9 | 34.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.4 | -5.59 | -1.46 | -35.8 | -8.93 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 25.4 | 26.4 | 33.7 | -9.16 | 26.9 |
| Capital Expenditures | -1.67 | -1.39 | -3.81 | -1.84 | -2.71 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -1.67 | -1.39 | -3.81 | -1.84 | -2.71 |
| Financing Cash Flow Items | -57.7 | -13.3 | -15.3 | -57.6 | -8.69 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -13.6 | -18.3 | -20.3 | 63.5 | -14.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.1 | 6.72 | 9.56 | 52.5 | 9.77 |